Leveraging OncoMD to identify synthetic lethal interactions between recurrently mutated genes
Most cancer therapies perform within a narrow therapeutic window causing numerous side effects and reducing the quality of life of cancer patients. Therefore, there is a need to develop new anti-cancer therapies of superior efficacy and minimal normal tissue toxicity. For this, identifying highly ef...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Science Planet Inc.
2017-12-01
|
| Series: | Canadian Journal of Biotechnology |
| Online Access: | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue-Supplement/cjb.2017-a213.pdf |